The major drug market drivers are rising incomes, easier access to high-quality healthcare facilities, and greater awareness of personal health and hygiene.
allergy drug market, industry overview, pharmaceutical industrySeveral government institutions, act as both challengers and motivators of the pharmaceutical sector and the allergy drug market.
allergy drug market, pharmaceutical industryIndian pharmaceutical market predominately comprises of generic drugs (70% revenue share) with lesser OTC drugs (21% revenue share) and a very few patented drugs (9% revenue share).
allergy drug market, industry overview, pharmaceutical industryIn the global pharmaceutical marketplace, the Indian pharmaceutical industry is at 13th position, in terms of value and has the 3rd largest volume (Department of Commerce, 2017).
allergy drug market, industry overview, market dynamics, pharmaceutical industryThe Drug Price Control Order (DPCO) was enacted by the Government of India in 1955. The latest amendments to the policy and regulations were made in 2013 and termed as DCPO-2013 (National Pharmaceutical Pricing Authority, 2018).
allergy drug market, industry overview, pharmaceutical industryFederal Food, Drug, and Cosmetic Act (FFDCA) of the United States were enacted to prevent the adulteration of food and drugs and their misbranding (Wozniak et al., 2012).
allergy drug market, industry overview, pharmaceutical industryThe pharmaceutical drug market comprises of expenditures, value generation, sales, production capabilities, and availability. However, the drug market is mainly determined by the sales or the production rate of the companies.
allergy drug market, industry overview, pharmaceutical industryThe Central Council of Indian Medicine (CCIM) is the statutory body under the Indian Medicine Central Council Act, 1970 incepted in the year 1971.
allergy drug market, ayush